TRINITAS HOSPITAL BEGINS ELECTIVE ANGIOPLASTY PROCEDURES
Joins other New Jersey hospitals in Atlantic C-Port benchmark program
Trinitas Hospital performed its first elective angioplasty procedure as part of the three-year study known as the Atlantic C-PORT Trial. Trinitas is one of nine hospitals in New Jersey participating in the study, which is a multi-state demonstration project that will assess the safety, quality and cost of elective angioplasty in hospitals that offer emergency angioplasty without onsite cardiac surgery backup. The NJ State Health Planning Board had approved Trinitas' application for eligibility for the Atlantic C-PORT study in October, 2005.
Coronary angioplasty involves the insertion of a catheter into a blocked artery in the heart. A small balloon on the end of the catheter is inflated, opening the artery and restoring blood flow to the heart.
The first elective angioplasty procedure at Trinitas Hospital was performed by Cardiologist Mathew Cholankeril, MD, and members of the interventional cardiology staff, under the direction of Fayez Shamoon, MD, director of Interventional Cardiology.
"Our participation in this benchmark study is significant for the 300,000 people who reside in the Trinitas Hospital service area who can now look to our hospital for life-saving elective angioplasty services," explained Gary S. Horan, FACHE, Trinitas President and Chief Executive Officer.
Since 2003, Trinitas Hospital has performed angioplasties only in emergency circumstances for patients experiencing active heart attack symptoms. "The hospital's angioplasty team has successfully performed 118 angioplasties in difficult emergency situations in the past three years," continued Mr. Horan, "with results indicating that we are certainly well-prepared to perform those same surgeries in purely elective circumstances. In fact, these emergency angioplasty procedures resulted in survival rates well above the national average for such procedures." He further noted that from January, 2005 through June, 2006, Trinitas Hospital performed more than 1,000 diagnostic catheterizations with zero mortality.
"The quality of Trinitas Hospital's cardiac program, both in terms of diagnostic cardiac catheterization and emergency angioplasty, is excellent," Mr. Horan explained, adding, "Based on our successful experience in emergency angioplasty, our appropriate volume of cases, and our overall patient diversity, Trinitas Hospital is proud to participate in this landmark study."
Posted: July 17, 2006